Monkeypox does not pose a Covid-style risk despite its swift spread, top health execs say
Global health concerns loomed over the World Economic Forum once again this year, but business leaders say they are not
Read more
Pfizer Inc
Pfizer CEO says he ‘wouldn’t worry much’ about monkeypox; cuts drug prices for low-income countries
Pfizer's CEO said Wednesday that he "wouldn't worry much" about a recent monkeypox outbreak that has seen cases surge in
Read more
Strategists pick their top stocks to beat rising prices and slowing growth — including some they say are ‘extremely cheap’
CNBC Pro identifies strategists' top stocks as the global economy battles rising inflation and slowing growth. Source link
Read more
When the market was tanking, these stocks were hitting all-time highs and could go even higher
While market losses were racking up, this group of stocks was breaking out to all-time highs and looks set for
Read more
Novavax confident Covid vaccine will receive FDA authorization in June after delays
If the FDA committee endorses Novavax's shot, the drug regulator is almost certain to rapidly authorize it for use in
Read more
U.S. will limit next generation Covid vaccines to high-risk people this fall if Congress doesn’t approve more funding
The White House has warned that it does not have enough money to buy next generation Covid vaccines for all
Read more
Kevin O’Leary says there are plenty of good places to ‘hide’ as interest rates rise
As interest rates in the U.S. rise, investors can put their money to work by looking at certain companies in
Read more
Stock futures are lower after big market reversal to start May
Investors are coming off a wild up-and-down session for stocks, with the S&P 500 rising on Monday after hitting a
Read more
Time for a fourth Covid vaccine dose? Here’s why medical professionals are skeptical
Medical professionals are undecided on whether a fourth dose of the Covid-19 vaccine would benefit the wider population. Source link
Read more